Last €101.55 EUR
Change Today +0.094 / 0.09%
Volume 48.4K
WCH On Other Exchanges
As of 3:35 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

wacker chemie ag (WCH) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/6/14 - €104.40
52 Week Low
05/19/14 - €76.04
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for WACKER CHEMIE AG (WCH)

Related News

No related news articles were found.

wacker chemie ag (WCH) Related Businessweek News

No Related Businessweek News Found

wacker chemie ag (WCH) Details

Wacker Chemie AG provides specialty chemical products worldwide. It operates through five divisions: WACKER SILICONES, WACKER POLYMERS, WACKER BIOSOLUTIONS, WACKER POLYSILICON, and Siltronic. The WACKER SILICONES division offers a portfolio of approximately 2,800 products ranging from silicone fluids and emulsions, resins, elastomers, and sealants, to silanes and pyrogenic silica grades, which are used as starting materials in the production of silicones. The WACKER POLYMERS division manufactures binders and polymeric additives, such as dispersible polymer powders and dispersions used in various industrial applications, or as base chemicals in paints, coatings, paper, and adhesives industries, as well as in the construction industry. The WACKER BIOSOLUTIONS division supplies customized biotech and catalog products for fine chemical sector, including pharmaceutical proteins, cyclodextrins, cysteine, polyvinyl acetate solid resins, organic intermediates, and acetylacetone. This division focuses on customer-specific solutions in the areas of food additives, pharmaceutical actives, and agrochemicals. The WACKER POLYSILICON division produces hyperpure polysilicon for the semiconductor, electronics, and solar sectors. The Siltronic division supplies silicon wafers for various semiconductor manufacturers that are used as raw materials for various semiconductor products, including discrete semiconductor components or microchips. The company was founded in 1914 and is headquartered in Munich, Germany.

16,724 Employees
Last Reported Date: 10/30/14
Founded in 1914

wacker chemie ag (WCH) Top Compensated Officers

Chief Executive Officer, President and Member...
Total Annual Compensation: €1.4M
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €1.1M
Member of Executive Board
Total Annual Compensation: €1.1M
Member of the Executive Board
Total Annual Compensation: €682.3K
Compensation as of Fiscal Year 2013.

wacker chemie ag (WCH) Key Developments

Andreas Biagosch Joins Wacker's Supervisory Board

Dr. Andreas H. Biagosch (59) has joined Wacker Chemie AG's Supervisory Board. He succeeds Dr. Bernd W. Voss, who has stepped down for health reasons. Since 2013, Biagosch has been Managing Director at Impacting I GmbH & Co.KG  and Impact GmbH (consulting and investment firms).

WACKER Group Opens New Health Center at Burghausen Site

WACKER Group has announced the opening of a new health center at its Burghausen site. Equipped with medical technology, the Center will provide flexible health care to the site's approximately 10,000 employees. WACKER invested around EUR 4 million in the new building.

Wacker Chemie AG Announces Preliminary Group Earnings Results for Fourth Quarter and Full Year Ended December 31, 2014

Wacker Chemie AG announced preliminary group earnings results for fourth quarter and full year ended December 31, 2014. For the quarter, sales totaled roughly €1.19 billion against €1.09 billion a year ago, up almost 10%. EBITDA growth was even stronger, coming in at €180 million against €158 million a year ago, 14% more than a year earlier. For the year, the company achieved total sales of €4.83 billion against €4.48 billion in 2013, 8% above the prior-year figure. The main reasons for this increase were volume gains at all business divisions and better prices for polysilicon. The group's earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to €1.04 billion against €679 million in 2013, a year-on-year increase of 53%. In addition to the positive operating performance, EBITDA was also driven higher by special income arising from terminated and restructured contracts with solar-industry customers. The group's earnings before interest and taxes (EBIT) reached €443 million against €114 million in 2013 according to preliminary calculations - an almost fourfold year-on-year increase. Net income was €195 million against €6 million in 2013. Capital expenditures amounted to €572 million against €504 million in 2013, according to preliminary figures - a project-related increase of more than 13% over a year earlier. The group's net cash flow grew strongly, to €216 million against €110 million in 2013 – 96% more than a year earlier. The main reason for the increase is the higher net income for the year. Net financial debt at the group rose by nearly €300 million, as expected, and amounted to €1.08 billion as of December 31, 2014 against €792 million as on December 31, 2013.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WCH:GR €101.55 EUR +0.094

WCH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arkema SA €66.71 EUR -0.21
Celanese Corp $58.25 USD +1.14
Clariant AG SFr.17.30 CHF +0.04
First Solar Inc $61.11 USD +1.37
K+S AG €28.87 EUR +0.064
View Industry Companies

Industry Analysis


Industry Average

Valuation WCH Industry Range
Price/Earnings 22.4x
Price/Sales 0.9x
Price/Book 2.1x
Price/Cash Flow 23.5x
TEV/Sales 0.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WACKER CHEMIE AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at